Bili Xia

Feasibility of iNKT cell and PD-1+CD8+ T cell-based immunotherapy in patients with lung adenocarcinoma: Preliminary results of a phase I/II clinical trial.

Jianqing Xu, Xiaoyan Zhang, Chenli Qiu, 2022, Clinical immunology.

Pathologically complete remission to combination of invariant NK T cells and anti-CD20 antibody in a refractory HIV+ diffuse large B-cell lymphoma patient.

Jianqing Xu, Xiaoyan Zhang, Jing Wang, 2022, Immunotherapy.

A new model of self-resolving leptospirosis in mice infected with a strain of Leptospira interrogans serovar Autumnalis harboring LPS signaling only through TLR4

Yung-Fu Chang, P. He, Haihan Xiao, 2017, Emerging microbes & infections.

Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors

Jianqing Xu, Chen Zhao, Xiaoyan Zhang, 2022, Frontiers in Bioengineering and Biotechnology.

Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1+CD8+ T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer

Jianqing Xu, Xiaoyan Zhang, Wei Zhang, 2023, Cancer research communications.